Support for Graduate, PDF and New Faculty Presenters at the 2022 American Society of Pharmacognosy Meeting
为 2022 年美国生药学会会议上的研究生、PDF 和新教师演讲者提供支持
基本信息
- 批准号:10469168
- 负责人:
- 金额:$ 3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAgricultureAmericanAreaBackBeautyBiologyCaliberCancer ControlCarbon DioxideChemicalsClinical ResearchCollaborationsCommunitiesComplementary MedicineCore FacilityCountryCryoelectron MicroscopyDevelopmentDictionaryDiseaseDyesEducationEducational workshopEmerging Communicable DiseasesEnvironmentEnvironmental ScienceEquilibriumEventFacultyFeesFosteringFundingFutureGoalsHealthHistorically Black Colleges and UniversitiesHumanInstitutionIslandKnowledgeLaboratoriesMarine BiologyMedicalMedicineMethodsMissionMovementMunicipalitiesNational Center for Complementary and Integrative HealthNational Oceanic and Atmospheric AdministrationNatural HistoryNatural ProductsNatureOilsPetroleumPharmaceutical PreparationsPharmacognosyPharmacologic SubstancePhotosynthesisPlantsPlayPopulation HeterogeneityPostdoctoral FellowProductionRecording of previous eventsResearchResearch PersonnelRoleScienceScientistSocial InteractionSocietiesSourceSouth CarolinaSoutheastern United StatesStandardizationStudentsTechniquesTherapeuticTherapeutic AgentsTrainingTraining and EducationTravelUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWomen&aposs GroupWorkbasecareercareer developmentcollegeconsumer productdrug developmentdrug discoveryglobal healthgraduate studentimprovedindigo dyeinnovationinstrumentinterestmedical schoolsmeetingsmembermen&aposs groupneglectnervous system disordernext generationoutreachprogramsprototyperecruitsmall moleculesocialstudent mentoringsymposiumsynthetic biologytranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
Natural products have provided humankind the key starting materials to support health by providing therapeutic
agents and structural templates for medicinal chemists. The field of natural products is rapidly evolving to fill
anticipated supply gaps due to the movement away from petroleum based energy, fine chemicals and
pharmaceuticals. Although only about 1% of every barrel of oil is used in the manufacture of pharmaceutical
products it is estimated petroleum supplies 99% of the starting materials for pharmaceutical and other consumer
products. Thus one of three key Aims of this meeting includes the replacement of petroleum based starting
materials for therapeutics with natural products. A second key aim for this meeting is an assessment of panomics
approaches to the discovery and development of natural product prototypes for the control of cancer and
emerging infectious diseases, including SARS-CoV2. Emerging methods involving CryoEM in drug discovery
and development will be featured at this meeting. The need for better controls for emerging infectious diseases
needs no explanation; however; the role of natural products as critical starting materials and new prototypes will
be addressed as part of the 2022 American Society of Pharmacognosy Conference. Finally, a third key aim of
the program is to assess the role that natural products and natural products investigators can play in controlling
carbon dioxide levels in the environment. This can take the form of photosynthesis of agriculture or direct
conversion of CO2 into the starting materials for pharmaceuticals and other consumer products. We fully
anticipate that NPs will serve the needs of human health in regard to new prototypes well into the future. This
conference will showcase many aspects of these emerging needs with cutting-edge approaches that are moving
the field forward at an accelerated pace. We have selected leaders in the field as conference chairs and speakers
that align well with the mission of the NCCIH including a significant number of speakers with expertise in
analytical techniques for evaluating and standardizing materials used as complementary medicines. This project
seeks funding to support the American Society of Pharmacognosy (ASP) meeting that will be held July 23-28th
in Charleston, SC. The ASP is the largest society in the USA that focuses on natural products. The ASP as well
as this conference focuses on molecules from nature and their application to improve human health. Support
from the NIH will help offset registration fees and assist with travel for students and new faculty from the US and
US Territories with a focus on regional HBCUs (historically black colleges and universities) of the South Eastern
US. Thus our final aim is to train the next generation of scientists through the recruitment and support attendees
from the PUIs with a focus on the Southeastern US.
项目概要/摘要
天然产品通过提供治疗作用为人类提供了支持健康的关键原材料
药物化学家的试剂和结构模板。天然产物领域正在迅速发展,以填补
由于石油能源、精细化学品和化学品的转移,预计出现供应缺口
药品。尽管每桶石油中只有约 1% 用于制药
据估计,石油为制药和其他消费品提供了 99% 的原材料
产品。因此,本次会议的三个关键目标之一包括取代石油基启动
用天然产品进行治疗的材料。这次会议的第二个关键目标是评估全景经济学
发现和开发用于控制癌症的天然产品原型的方法
新出现的传染病,包括 SARS-CoV2。药物发现中涉及 CryoEM 的新兴方法
此次会议的主题是发展。需要更好地控制新出现的传染病
不需要解释;然而;天然产物作为关键原材料和新原型的作用将
将作为 2022 年美国生药学学会会议的一部分进行讨论。最后,第三个关键目标
该计划旨在评估天然产物和天然产物研究人员在控制中可以发挥的作用
环境中的二氧化碳水平。这可以采取农业光合作用或直接的形式
将二氧化碳转化为药品和其他消费品的原材料。我们完全
预计纳米颗粒将在未来通过新原型满足人类健康的需求。这
会议将通过正在发展的前沿方法展示这些新兴需求的许多方面
该领域正在加速前进。我们选择了该领域的领导者作为会议主席和发言人
与 NCCIH 的使命高度契合,其中包括大量具有以下专业知识的演讲者:
用于评估和标准化用作补充药物的材料的分析技术。这个项目
寻求资金支持将于 7 月 23 日至 28 日举行的美国生药学会 (ASP) 会议
在南卡罗来纳州查尔斯顿。 ASP 是美国最大的专注于天然产品的协会。还有ASP
因为本次会议的重点是来自自然界的分子及其在改善人类健康方面的应用。支持
美国国立卫生研究院 (NIH) 的资助将帮助抵消注册费,并协助来自美国和美国的学生和新教师的旅行
美国领土,重点关注东南部地区 HBCU(历史悠久的黑人学院和大学)
我们。因此,我们的最终目标是通过招募和支持参与者来培训下一代科学家
来自 PUI,重点关注美国东南部地区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark T Hamann其他文献
Platanosides from Platanus × acerifolia: New molecules, SAR, and target validation of a strong lead for drug-resistant bacterial infections and the associated sepsis.
悬铃木中的悬铃木苷:新分子、SAR 以及对耐药细菌感染和相关脓毒症的强大先导作用的靶标验证。
- DOI:
10.1016/j.bioorg.2024.107103 - 发表时间:
2024-01-01 - 期刊:
- 影响因子:5.1
- 作者:
Xi;Ze;E. Osman;Xiao;Y. Choo;Menny M Benjamin;Juan Xiong;Mark T Hamann - 通讯作者:
Mark T Hamann
Informatics and Computational Approaches for the Discovery and Optimization of Natural Product-Inspired Inhibitors of the SARS-CoV-2 2'-O-Methyltransferase.
- DOI:
10.1021/acs.jnatprod.3c00875 - 发表时间:
2024-01-19 - 期刊:
- 影响因子:5.1
- 作者:
George S Hanna;Menny M Benjamin;Y. Choo;Ramyani De;Raymond F. Schinazi;Sarah E Nielson;J. Hevel;Mark T Hamann - 通讯作者:
Mark T Hamann
Targeting Sine Oculis Homeoprotein 1 (SIX1): A Review of Oncogenic Roles and Potential Natural Product Therapeutics
靶向正弦眼同源蛋白 1 (SIX1):致癌作用和潜在天然产物治疗的综述
- DOI:
10.1016/j.heliyon.2024.e33204 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:4
- 作者:
Zhiwei Bian;Menny M Benjamin;Lucas Bialousow;Yintai Tian;G. A. Hobbs;Dev Karan;Y. Choo;Mark T Hamann;Xiaojuan Wang - 通讯作者:
Xiaojuan Wang
Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice.
Manzamine A 通过阻断 E2F8-DNA 相互作用来减少雄激素受体的转录和合成,并有效抑制小鼠前列腺肿瘤的生长。
- DOI:
10.1002/1878-0261.13637 - 发表时间:
2024-04-11 - 期刊:
- 影响因子:6.6
- 作者:
Dev Karan;S. Dubey;S. Gunewardena;Kenneth A Iczkowski;Manohar Singh;Pengyuan Liu;Angelo Poletti;Y. Choo;Hui;Mark T Hamann - 通讯作者:
Mark T Hamann
Mark T Hamann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark T Hamann', 18)}}的其他基金
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
阿留申胺类生物碱的合成与优化
- 批准号:
10799135 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Synthesis and Optimization of the Aleutianamine Class of Alkaloids
阿留申胺类生物碱的合成与优化
- 批准号:
10345968 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
- 批准号:
8339007 - 财政年份:2012
- 资助金额:
$ 3万 - 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
- 批准号:
9127149 - 财政年份:2012
- 资助金额:
$ 3万 - 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
- 批准号:
8707979 - 财政年份:2012
- 资助金额:
$ 3万 - 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
- 批准号:
8912993 - 财政年份:2012
- 资助金额:
$ 3万 - 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
- 批准号:
8541704 - 财政年份:2012
- 资助金额:
$ 3万 - 项目类别:
Natural Product HCV Drugs from Rare Plant-Microbe Interactions
来自稀有植物-微生物相互作用的天然产物 HCV 药物
- 批准号:
9230277 - 财政年份:2012
- 资助金额:
$ 3万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Research Employing Environmental Systems and Occupational Health Policy Analyses to Interrupt the Impact of Structural Racism on Agricultural Workers and Their Respiratory Health (RESPIRAR)
利用环境系统和职业健康政策分析来中断结构性种族主义对农业工人及其呼吸系统健康的影响的研究(RESPIRAR)
- 批准号:
10474690 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Research Employing Environmental Systems and Occupational Health Policy Analyses to Interrupt the Impact of Structural Racism on Agricultural Workers and Their Respiratory Health (RESPIRAR)
利用环境系统和职业健康政策分析来中断结构性种族主义对农业工人及其呼吸系统健康的影响的研究(RESPIRAR)
- 批准号:
10689054 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Flow cytometer Cell Sorter for Biosafety Level-3 Facility
生物安全三级设施流式细胞仪细胞分选仪
- 批准号:
10177283 - 财政年份:2021
- 资助金额:
$ 3万 - 项目类别:
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
ADELANTE 试验:测试一种多层次方法,以改善拉丁裔糖尿病患者的家庭粮食不安全和血糖控制
- 批准号:
10309810 - 财政年份:2021
- 资助金额:
$ 3万 - 项目类别: